Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome

Archive ouverte

Jutant, Etienne-Marie | Meyrignac, Olivier | Beurnier, Antoine | Jaïs, Xavier | Pham, Tai | Morin, Luc | Boucly, Athénaïs | Bulifon, Sophie | Figueiredo, Samy | Harrois, Anatole | Jevnikar, Mitja | Noël, Nicolas | Pichon, Jérémie | Roche, Anne | Seferian, Andrei | Soliman, Samer | Duranteau, Jacques | Becquemont, Laurent | Monnet, Xavier | Sitbon, Olivier | Bellin, Marie-France | Humbert, Marc | Savale, Laurent | Montani, David

Edité par CCSD ; European Respiratory Society -

International audience. Rationale: The characteristics of patients with respiratory complaints and/or lung radiologic abnormalities after hospitalisation for coronavirus disease 2019 (COVID-19) are unknown. The objectives were to determine their characteristics and the relationships between dyspnoea, radiologic abnormalities and functional impairment.
Methods: In the COMEBAC (Consultation Multi-Expertise de Bicêtre Après COVID-19) cohort study, 478 hospital survivors were evaluated by telephone 4 months after hospital discharge, and 177 who had been hospitalised in an intensive care unit (ICU) or presented relevant symptoms underwent an ambulatory evaluation. New-onset dyspnoea and cough were evaluated, and the results of pulmonary function tests and high-resolution computed tomography of the chest were collected.
Results: Among the 478 patients, 78 (16.3%) reported new-onset dyspnoea, and 23 (4.8%) new-onset cough. The patients with new-onset dyspnoea were younger (56.1±12.3 versus 61.9±16.6 years), had more severe COVID-19 (ICU admission 56.4% versus 24.5%) and more frequent pulmonary embolism (18.0% versus 6.8%) (all p≤0.001) than patients without dyspnoea. Among the patients reassessed at the ambulatory care visit, the prevalence of fibrotic lung lesions was 19.3%, with extent <25% in 97% of the patients. The patients with fibrotic lesions were older (61±11 versus 56±14 years, p=0.03), more frequently managed in an ICU (87.9 versus 47.4%, p<0.001), had lower total lung capacity (74.1±13.7 versus 84.9±14.8% pred, p<0.001) and diffusing capacity of the lung for carbon monoxide ( D LCO ) (73.3±17.9 versus 89.7±22.8% pred, p<0.001). The combination of new-onset dyspnoea, fibrotic lesions and D LCO <70% pred was observed in eight out of 478 patients.
Conclusions: New-onset dyspnoea and mild fibrotic lesions were frequent at 4 months, but the association of new-onset dyspnoea, fibrotic lesions and low D LCO was rare.

Suggestions

Du même auteur

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

Archive ouverte | Beurnier, Antoine | CCSD

International audience. Background Dyspnoea is a common persistent symptom after COVID-19. Whether it is associated with functional respiratory disorders remains unclear. Methods We assessed the proportion and chara...

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation

Archive ouverte | Beurnier, Antoine | CCSD

International audience. Background Viral respiratory infections are the main causes of asthma exacerbation. The susceptibility of asthmatics to develop an exacerbation when they present with severe pneumonia due to ...

Radiological pulmonary sequelae after COVID-19 and correlation with clinical and functional pulmonary evaluation: results of a prospective cohort

Archive ouverte | Soliman, Samer | CCSD

International audience

Chargement des enrichissements...